New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:09 EDTMNKDMannKind rallies after global licensing agreement for Afrezza
The company and Sanofi (SNY) entered into a worldwide exclusive agreement to develop and commercialize Afrezza Inhalation Powder. The stock is up over 15.5% at time of writing to $9.40, off earlier highs. At that price, next resistance is at $9.63. Support is at $9.29.
News For MNKD From The Last 14 Days
Check below for free stories on MNKD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
05:51 EDTMNKDStocks with implied volatility movement; OREX MNKD
Stocks with implied volatility movement; Orexigen (OREX) 91, MannKind (MNKD) 60 according to iVolatility.
September 10, 2014
06:02 EDTMNKDMannKind implied volatility of 56 at lower end of index mean range
Subscribe for More Information
September 9, 2014
06:04 EDTMNKDMannKind implied volatility of 56 at lower end of index mean range

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use